Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

INTRODUCTION: Data from the SINGLE trial demonstrated that 88% of treatment-naive HIV-1 patients treated with dolutegravir and abacavir/lamivudine (DTG+ABC/3TC) achieved viral suppression at 48 weeks compared with 81% of patients treated with efavirenz/tenofovir disoproxil fumarate/emtricitabine (EF...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Int AIDS Soc
Main Authors: Peng, Siyang, Tafazzoli, Ali, Dorman, Emily, Rosenblatt, Lisa, Villasis-Keever, Angelina, Sorensen, Sonja
Format: Artigo
Sprog:Inglês
Udgivet: International AIDS Society 2014
Fag:
Poster Sessions – Abstract P073
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224816/
https://ncbi.nlm.nih.gov/pubmed/25394109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19605
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker